Dr. Michael M. Marvi, MD, MS

Dr. Marvi practices at Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services.

Dr. Marvi's NPI, 1205054129, was assigned on April 23, 2007. Dr. Marvi graduated from Tel Aviv University Sackler in 2004. Dr. Marvi holds California license A96606.

Dr. Marvi's primary practice is Providence Saint Joseph Medical Center, at 501 South Buena Vista Street, Burbank, CA 91505 in Los Angeles County. The practice phone is (818) 843-5111.

Dr. Marvi's primary practice is Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services. Dr. Marvi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is Providence Medical Group, Oregon. Dmand AI also links Dr. Marvi to 3 more hospitals and 15 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marvi practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Marvi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Marvi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Marvi's licenses on file in 8 states: California, Washington, Alaska, Idaho, Montana, New Mexico, Oregon and Texas.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury and hereditary polyneuropathy among the conditions Dr. Marvi treats.

CMS data shows 1,188 Medicare services from Dr. Marvi across 9 procedure codes in 2024, for 401 Medicare patients. Medicare paid $85,165 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 401 Medicare patients who saw Dr. Marvi in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marvi's median patient age at 68, with 63% women.

In 2024, Dr. Marvi wrote 1,091 Medicare Part D claims for 222 patients. 90% of them were for generic drugs. CMS names the drug for 830 of them, across 23 drugs with 11 or more claims each, at $142,224 in total drug cost. In 2023, CMS named 497 claims across 18 drugs.

Dr. Marvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marvi as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Marvi in 2013. Dr. Marvi's most frequent co-authors are Claudia F. Lucchinetti, MD and Ronald Bert Ziman, MD.

CMS Open Payments shows 153 general payments to Dr. Marvi from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Abbvie Inc. paid the most, $3,663.

Dr. Marvi graduated from Tel Aviv University Sackler in 2004.

Dr. Marvi is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.